Denna sida på svenska
Loading profile information...

Publications

Epigenetics applied to psychiatry: Clinical opportunities and future challenges
Kular L, Kular S
Psychiatry and clinical neurosciences 2018;():-

Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
Lohcharoenkal W, Das Mahapatra K, Pasquali L, Crudden C, Kular L, Akkaya Ulum Yz, et al
The Journal of investigative dermatology 2018;():-

Decreased Expression of IFNG-AS1, IFNG and IL-1B Inflammatory Genes in Medicated Schizophrenia and Bipolar Patients
Ghafelehbashi H, Pahlevan Kakhki M, Kular L, Moghbelinejad S, Ghafelehbashi Sh
Scandinavian journal of immunology 2017;86(6):479-485

Epigenetic research in multiple sclerosis: progress, challenges, and opportunities
Zheleznyakova Gy, Piket E, Marabita F, Pahlevan Kakhki M, Ewing E, Ruhrmann S, et al
Physiological genomics 2017;49(9):447-461

Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes
Ruhrmann S, Ewing E, Piket E, Kular L, Cetrulo Lorenzi Jc, Fernandes Sj, et al
Multiple sclerosis (Houndmills, Basingstoke, England) 2017;():1352458517721356-

Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship
Marabita F, Almgren M, Sjöholm Lk, Kular L, Liu Y, James T, et al
Scientific reports 2017;7(1):14589-

Usability of human Infinium MethylationEPIC BeadChip for mouse DNA methylation studies
Needhamsen M, Ewing E, Lund H, Gomez-cabrero D, Harris Ra, Kular L, et al
BMC bioinformatics 2017;18(1):486-

Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Ruhrmann S, Stridh P, Kular L, Jagodic M
The international journal of biochemistry & cell biology 2015;67():49-57

Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats
Bergman P, James T, Kular L, Ruhrmann S, Kramarova T, Kvist A, et al
Journal of immunology (Baltimore, Md. : 1950) 2013;190(8):4066-75

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9
Kular L, Rivat C, Lelongt B, Calmel C, Laurent M, Pohl M, et al
Journal of neuroinflammation 2012;9():36-

Chemokines and chemokine receptors: new actors in neuroendocrine regulations
Rostène W, Guyon A, Kular L, Godefroy D, Barbieri F, Bajetto A, et al
Frontiers in neuroendocrinology 2011;32(1):10-24

The CCN family: a new class of inflammation modulators?
Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C
Biochimie 2011;93(3):377-88

NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins
Le Dréau G, Kular L, Nicot Ab, Calmel C, Melik-parsadaniantz S, Kitabgi P, et al
Glia 2010;58(12):1510-21

Show all publications